Alvaro
Lassaletta Atienza
Consultor Médico
Karolinska University Hospital
Estocolmo, SueciaPublications in collaboration with researchers from Karolinska University Hospital (1)
2023
-
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial
JAMA Oncology, Vol. 9, Núm. 12, pp. 1688-1695